Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

v2.4.1.9
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)
3 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Cash flows from operating activities:    
Net loss $ (4,781,571)us-gaap_NetIncomeLoss $ (281,606)us-gaap_NetIncomeLoss
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation 1,869us-gaap_Depreciation 1,417us-gaap_Depreciation
Amortization of intangible assets and website 2,598,461us-gaap_AmortizationOfIntangibleAssets 453,647us-gaap_AmortizationOfIntangibleAssets
Non-cash equity compensation 685,753us-gaap_ShareBasedCompensation 680,627us-gaap_ShareBasedCompensation
Stock issued for services 750,334us-gaap_StockOptionPlanExpense   
Deferred tax liability (161,984)us-gaap_IncreaseDecreaseInOtherDeferredLiability   
Deferred tax asset (2,335,116)us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets   
Non-cash interest, discounts and financing costs 613,719MARA_NoncashInterestPikInterestFinanceCosts   
Other non-cash adjustments 83,148us-gaap_OtherNoncashIncomeExpense   
Changes in operating assets and liabilities    
Accounts receivable (546,101)us-gaap_IncreaseDecreaseInAccountsReceivable (10,000)us-gaap_IncreaseDecreaseInAccountsReceivable
Prepaid expenses 26,248us-gaap_IncreaseDecreaseInPrepaidExpense (8,015)us-gaap_IncreaseDecreaseInPrepaidExpense
Accounts payable and accrued expenses 1,920,185us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities 964,297us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
Net cash provided by (used in) operating activities (1,145,055)us-gaap_NetCashProvidedByUsedInOperatingActivities 1,800,367us-gaap_NetCashProvidedByUsedInOperatingActivities
Cash flows from investing activities:    
Purchase of property, equipment and other intangible assets (37,147)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment   
Net cash provided by (used in) investing activities (37,147)us-gaap_NetCashProvidedByUsedInInvestingActivities   
Cash flows from financing activities:    
Payment on note payable in connection with the acquisition of IP Liquidity (1,068,750)us-gaap_RepaymentsOfNotesPayable   
Payment on assumed note payable in connection with the acquisition of Orthophoenix (3,750,000)us-gaap_RepaymentsOfRelatedPartyDebt   
Payment on note payable in connection with the acquisition of Dynamic Advances (905,000)MARA_PaymentOnNotePayableInConnectionWithAcquisitionOfDynamicAdvances   
Payment on note payable in connection with the acquisition of Medtech and Orthophoenix (3,000,000)MARA_PaymentOnNotePayableInConnectionWithAcquisitionOfMedtechAndOrthophoenix   
Payment on note payable in connection with the acquisition of Sarif (276,250)MARA_PaymentOnNotePayableInConnectionWithAcquisitionOfSarif   
Repayment on convertible notes (5,050,000)us-gaap_RepaymentsOfConvertibleDebt   
Cash received upon issuance of notes payable, net of $400,000 loan fee 19,600,000us-gaap_ProceedsFromConvertibleDebt   
Cash received upon exercise of warrants 18,750us-gaap_ProceedsFromStockOptionsExercised   
Net cash provided by financing activities 5,568,750us-gaap_NetCashProvidedByUsedInFinancingActivities   
Effect of exchange rate changes in cash 8,852us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents   
Net increase in cash 4,395,400us-gaap_CashPeriodIncreaseDecrease 1,800,366us-gaap_CashPeriodIncreaseDecrease
Cash at beginning of year 5,082,569us-gaap_Cash 3,610,262us-gaap_Cash
Cash at end of period 9,477,969us-gaap_Cash 5,410,628us-gaap_Cash
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:    
Cash paid for: Interest expense and loan fees 317,821us-gaap_InterestPaid   
Cash paid for: Taxes Paid 8,260us-gaap_IncomeTaxesPaidNet   
Loan fees 400,000us-gaap_AmortizationOfDeferredLoanOriginationFeesNet   
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES    
Common stock issued in conjunction with notes payable 1,000,000MARA_CommonStockIssuedInConjunctionWithNotesPayable   
Warrants issued in conjunction with notes payable 318,679MARA_WarrantsIssuedInConjunctionWithNotesPayable   
Revenue share liability incurred in conjunction with notes payable $ 1,000,000MARA_RevenueShareLiabilityIncurredInConjunctionWithNotesPayable